As Industries Become Automated and Robots Become Increasingly Sophisticated, the Law Struggles to Keep Pace
Since Mary Shelly penned the novel Frankenstein; or, The Modern Prometheus some two centuries ago (a story about a scientist named Victor Frankenstein), one of humanity's greatest fears has been that we will wind up creating our own successors – and that those successors will eventually cause our demise. Two recent incidents highlight the dangers of that scenario coming to pass.
Evidence of what is known as Chronic Traumatic Encephalopathy (CTE) among professional football players has been known to medical science for at least twenty years.
Last Thursday, an eight-member jury in a New Jersey state court awarded $23 million in compensatory damages to Mary McGinnis after finding that a pelvic mesh manufactured by C.R. Bard, Inc. was the cause of her pain and suffering. Her husband, Thomas McGinnis, was awarded an additional $10 million for loss of consortium.
Jury Finds Johnson & Johnson, Imerys Liable in Lawsuit Claiming Talcum Powder Caused Mesothelioma Cancer
In a stunning verdict handed down in a federal court in New Jersey, a jury has ordered pharmaceutical giant Johnson & Johnson and its talc supplier, Imerys, to pay $37 million to a 46-year-old man who alleged that his mesothelioma was caused by his regular use of the defendant's talc-containing products over the course of his lifetime. The trial, which ended yesterday, is the most recent bellwether case over allegations that Johnson & Johnson's flagship products, Baby Powder and Shower to Shower, are carcinogenic.
The Tsunami of Litigation Races Toward Facebook's Shores: Are the Social Media Giant's Days Numbered?
The last few weeks have not been good ones for billionaire entrepreneur Mark Zuckerberg. In the wake of revelations over its handling of user data, its business practices and how its platform was used to manipulate the 2016 elections, Facebook's stock value has plummeted as investors exit their positions in the company – and so far, there have been four lawsuits filed over its gathering and use of personal information.
Federal Judge Who Previously Rejected 9/11 Lawsuit Against Saudi Arabia is Now Allowing Claims to Go Forward
U.S. District Judge Peter Messitte issued an order on Wednesday that has cleared the way for a lawsuit against Donald Trump to proceed. As a result, the Attorneys General of Washington D.C. and the state of Maryland now have legal standing to bring their cases against Trump over his alleged violations of the Emoluments Clause of the U.S. Constitution.
The medical community has been dealing with addiction to opioid-based pain medication for over 150 years. It is not a new issue. It has only been in recent years that the rate of addiction has reached crisis proportions. In 2016 alone, opioid overdose claimed 42,000 lives – more than the number of those lost to breast cancer.
Last year, massive cyber-security failures at Equifax exposed personal information on over 145 million consumers to criminal hackers. This information includes Social Security numbers, credit card information, driver's licenses, telephone numbers and more. It is a clear case of gross negligence on part of Equifax, which waited several months before informing consumers.
Department of Justice Announces It Will Side With Plaintiffs in Opioid Lawsuit – But Will It, Really?
Earlier this week, the current U.S. Attorney General Jefferson Sessions announced that the Department of Justice intends to file a “statement of interest” in filing its own lawsuit against opioid manufacturers. In a media statement, Sessions alleged that opioid manufacturers and distributors had used “false, deceptive, and unfair marketing” in order to market their products.
Despite demonstrated dangers and side effects, which are the primary cause of action in the dozens of lawsuits currently part of a mass tort action, the atypical antipsychotic medication Abilify remains on pharmacy shelves.
VARUBI® (rolapitant) was originally developed by Schering-Plough, which was taken over by Merck & Co. in November 2009. Currently, it has been licensed by Tesaro Inc., a relatively new biopharmaceutical company specializing in the development and marketing of cancer medications. It is primarily indicated for chemotherapy patients experiencing nausea and vomiting as a result of their treatment.
Of the five largest mass lawsuits either underway or scheduled for trial in 2018, three are about prescription drugs, with a fourth one listing a defective medical device as the cause of action. These cases involve not only negligence, failure to warn; and product defects; but in at least one of the cases the defendant is alleged to have engaged in criminal acts.
Drugmaker Allergan, which has most recently come under fire over the opioid-based medication Viberzi, has been targeted in numerous lawsuits over the years for many reasons. In the wake of 120 FDA reports of serious pancreatic injury and death attributed to Viberzi, Allergan is currently under investigation by law firms across the country on behalf of patients without gall bladders who have been injured by the medication.
Figures from the Centers for Disease Control and Prevention indicate that approximately 50,000 women a year in the U.S. suffer life-threatening complications giving birth – and as many as 900 of those women die. Those who survive often wind up disabled, traumatized and/or sterile.